Interim CFO John Kallassy will be leaving the Company on January 10, 2025, to pursue other business opportunities. In his place, the Company has retained Mr. James O’Brien as CFO advisor. Over the short term, he will assist the Company in strategic initiatives, business development, and financial matters. Mr. O’Brien is the founder of Great Island Advisors, a firm dedicated to leading and growing public and privately held businesses.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AWH:
- Aspira Women’s Health files to sell 16M shares of common stock, warrants
- Aspira Women’s Health CFO Resignation and Leadership Update
- Aspira Women’s Health CEO Transition and Leadership Change
- Akari Therapeutics appoints Torsten Hombeck as CFO
- Aspira CEO Nicole Sandford to depart, Sandra Milligan named interim
Questions or Comments about the article? Write to editor@tipranks.com